Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis

J Virol. 2014 Mar;88(5):2786-98. doi: 10.1128/JVI.03025-13. Epub 2013 Dec 18.

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) Tax protein is considered to play a central role in the process that leads to adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 Tax-expressing cells show resistance to apoptosis induced by Fas ligand (FasL) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). The regulation of Tax on the autophagy pathway in HeLa cells and peripheral T cells was recently reported, but the function and underlying molecular mechanism of the Tax-regulated autophagy are not yet well defined. Here, we report that HTLV-1 Tax deregulates the autophagy pathway, which plays a protective role during the death receptor (DR)-mediated apoptosis of human U251 astroglioma cells. The cellular FLICE-inhibitory protein (c-FLIP), which is upregulated by Tax, also contributes to the resistance against DR-mediated apoptosis. Both Tax-induced autophagy and Tax-induced c-FLIP expression require Tax-induced activation of IκB kinases (IKK). Furthermore, Tax-induced c-FLIP expression is regulated through the Tax-IKK-NF-κB signaling pathway, whereas Tax-triggered autophagy depends on the activation of IKK but not the activation of NF-κB. In addition, DR-mediated apoptosis is correlated with the degradation of Tax, which can be facilitated by the inhibitors of autophagy.

Importance: Our study reveals that Tax-deregulated autophagy is a protective mechanism for DR-mediated apoptosis. The molecular mechanism of Tax-induced autophagy is also illuminated, which is different from Tax-increased c-FLIP. Tax can be degraded via manipulation of autophagy and TRAIL-induced apoptosis. These results outline a complex regulatory network between and among apoptosis, autophagy, and Tax and also present evidence that autophagy represents a new possible target for therapeutic intervention for the HTVL-1 related diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Autophagy* / drug effects
  • Autophagy* / genetics
  • CASP8 and FADD-Like Apoptosis Regulating Protein / genetics*
  • Cell Line
  • Enzyme Activation
  • Gene Products, tax / genetics
  • Gene Products, tax / metabolism*
  • Human T-lymphotropic virus 1 / genetics
  • Human T-lymphotropic virus 1 / metabolism*
  • Humans
  • I-kappa B Kinase / metabolism
  • Models, Biological
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Phagosomes / metabolism
  • Proteolysis
  • Receptors, Death Domain / metabolism*
  • Signal Transduction* / drug effects
  • TNF-Related Apoptosis-Inducing Ligand / metabolism
  • TNF-Related Apoptosis-Inducing Ligand / pharmacology
  • Transcriptional Activation

Substances

  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • Gene Products, tax
  • NF-kappa B
  • Receptors, Death Domain
  • TNF-Related Apoptosis-Inducing Ligand
  • tax protein, Human T-lymphotrophic virus 1
  • I-kappa B Kinase